# RANOLAZINE
> **ANDA210407** · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2025-02-04
## Drug
- **FDA Application Number:** ANDA210407
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RANOLAZINE
- **Generic name:** Ranolazine
- **Active ingredients:** RANOLAZINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TORRENT
- **First approval:** 2025-02-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210407)
---
*MORVS · CC0 1.0*